Jiangsu Hengrui Medicine Co.,Ltd.’s Net Profit Dropped 14.9% in 2022

Jiangsu Hengrui Medicine Co.,Ltd. (江苏恒瑞医药股份有限公司) (600276.SH) reported a net profit of 3.8 billion yuan in 2022, down 14.9% year-on-year.

Meanwhile, the company posted 21.3 billion yuan in revenue, down 17.9% year-on-year.

At the end of the reporting period, it had 42.4 billion yuan in total assets and 3.9 billion yuan in total liabilities, with a liability-to-asset ratio of 9.3%.